- 全部删除
您的购物车当前为空
Befotertinib (D-0316) 是一种 EGFR 酪氨酸激酶抑制剂,可用于 EGFR T790M 阳性非小细胞肺癌的研究。


为众多的药物研发团队赋能,
让新药发现更简单!
Befotertinib (D-0316) 是一种 EGFR 酪氨酸激酶抑制剂,可用于 EGFR T790M 阳性非小细胞肺癌的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 823 | In stock | |
| 5 mg | ¥ 1,980 | In stock | |
| 10 mg | ¥ 3,290 | In stock | |
| 25 mg | ¥ 5,280 | In stock | |
| 50 mg | ¥ 7,260 | In stock | |
| 100 mg | ¥ 9,790 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,580 | In stock |
Befotertinib 相关产品
| 产品描述 | Befotertinib (D-0316) is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer. |
| 别名 | D-0316, Befotertinib |
| 分子量 | 567.61 |
| 分子式 | C29H32F3N7O2 |
| CAS No. | 1835667-63-4 |
| Smiles | COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc1nccc(n1)-c1cn(CC(F)(F)F)c2ccccc12 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 60 mg/mL (105.71 mM), Sonication and heating to 60℃ are recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容